Compare QURE & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | OSIS |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 2013 | 1997 |
| Metric | QURE | OSIS |
|---|---|---|
| Price | $24.11 | $194.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | $59.78 | ★ $273.29 |
| AVG Volume (30 Days) | ★ 1.7M | 177.1K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | 2.76 |
| EPS | N/A | ★ 1.51 |
| Revenue | $13,107,000.00 | ★ $1,089,286,000.00 |
| Revenue This Year | $44.21 | $6.95 |
| Revenue Next Year | $398.45 | $6.69 |
| P/E Ratio | ★ N/A | $129.43 |
| Revenue Growth | N/A | ★ 13.35 |
| 52 Week Low | $8.73 | $186.50 |
| 52 Week High | $51.72 | $311.72 |
| Indicator | QURE | OSIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 43.26 |
| Support Level | $20.63 | $191.60 |
| Resistance Level | $26.01 | $202.87 |
| Average True Range (ATR) | 1.93 | 6.85 |
| MACD | 0.68 | -0.51 |
| Stochastic Oscillator | 57.62 | 12.53 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Geographically, the majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.